Stem Cells CDMO

Stem Cell CDMO

Stem Cell CDMO

Throughout our journey in developing stem cell medicine, GWOXI has established multiple platforms spanning the entire industry chain, including clinical grade stem cell preparation, clinical grade cell storage, and clinical grade cell product testing.
 

Our Platforms:

 
  • 1. Clinical Grade Stem Cell Preparation Platform:Ensures high-quality and safe stem cell preparations for clinical application.
  • 2. Clinical Grade Cell Storage Platform: Provides secure and compliant storage solutions for clinical grade cells.
  • 3. Clinical Grade Cell Product Testing Platform: Offers comprehensive testing services to ensure the safety and efficacy of cell therapy products.
  • 4. Service and Compliance: So far, these platforms have served several domestic cell therapy developers and clinicians.

 

 

Our technologies are based on our core values: Innovation, Proficiency, and Responsibility. Each platform is fully compliant with the medical regulations in Taiwan. Additionally, with a self-demanding spirit, we maintain our services' quality by subcontracting third parties to compare the test results and ensure the our services’ quality annually.

 

Collaborations and Achievements:

 

We have signed several agreements with domestic hospitals and clinics to apply stem cell therapy treatment through special regulation for cell therapy (SRCT) in Taiwan. We have also assisted four clinics in obtaining 100% approval from the Joint Commission of Taiwan, allowing these clinics to legally apply cell therapy.

 
Commitment to Excellence:

 

To meet our customers' expectations, we are committed to continuously improving our technologies and providing high quality services. We strive to develop novel stem cell technologies to provide solutions to clinicians and address unmet medical needs, contributing to the whole pharmaceutical industry.

 

Service Workflow:

 

  1. 1. Consultation
    Share your sample details and needs. 
  2. 2. Agreement
    Confirm terms, sign NDA and contract.
  3. 3. Sample Processing
    Receive, inspect, and prepare samples.
  4. 4. Manufacturing & QC
    Cell culture, testing, and packaging.
  5. 5. Delivery & Report
    Final product with comprehensive CoA.

 

For further inquiries or quotation requests, please feel free to contact us.

Press Releases

Press Releases
NEWS
  • /userfiles/images/news/20250729055948126.jpg
    26
    2025
    09
    Press Releases
    GWOXI Stem Cell Secures Taiwan Invention Patent for Stem Cell-Derived Composition in Wound Healing

  • /userfiles/images/news/250909/20250924013519855.jpg
    09
    2025
    09
    Press Releases
    GWOXI Stem Cell Expands Cross-Border Collaborations — Engaging Potential Partners in Thailand

  • /userfiles/images/news/250822/20250924014457286.jpg
    22
    2025
    08
    Press Releases
    GWOXI Stem Cell Partners with Malaysia’s Cell 101 to Expand into the Asia-Pacific Regenerative Medicine Market